Peer-reviewed
1. COVID-19 Excess Mortality Collaborators: Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality,2020–21 Lancet (2022): https://doi.org/10.1016/S0140-6736(21)02796-3
2. Covid-19 National Preparedness Collaborators: Pandemic preparedness andcovid-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept30, 2021. Lancet (2022): https://doi.org/10.1016/S0140-6736(22)00172-6
3. COVID-19 Cumulative Infection Collaborators: Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021:a statistical analysis. Lancet. 2022: https://doi.org/10.1016/S0140-6736(22)00484-6
4. COVID-19 Forecasting Team. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1.Epub 2022 Feb 24. Erratum in: Lancet. 2022 Apr 16;399(10334):1468. PMID:35219376; PMCID: PMC8871594.
5. Yigezu A, Mirkuzie AH, Misganaw A, Tesfaye L, Tilahun G, Zergaw A, Hailu A, AbateE, Asnake W. The Indirect Impact of COVID-19 Pandemic on Maternal and Child Mortality in Ethiopia: A Modelling Study, 2020.http://dx.doi.org/10.2139/ssrn.3694748
6. Ayele W, Tesfaye L, Abagero A, Taye G, Abate B, Habtamu T, et al. COVID-19Epidemic trajectory modeling results for Ethiopia. Ethiop J Heal Dev. 2021;35: 25–32.
7. Endeshaw, F.B., Getnet, F., Temesgen, A.M., Mirkuzie, A.H, Tesfaye, L., Kefyalew A.,Birhanie, S.K. (2022). Effects of climatic factors on COVID19 transmission inEthiopia. Scientific Reports, 12(1), 19722. https://doi.org/10.1038/s41598022240249
8. Hendrix N, Warkaye S, Tesfaye L, Woldekidan MA, Arja A, Sato R, Memirie ST,Mirkuzie AH, Getnet F, Verguet S. Estimated travel time and staffing constraints to accessing the Ethiopian health care system: A two-step floating catchment area analysis. J Glob Health. 2023 Jan 27;13:04008. doi: 10.7189/jogh.13.04008.PMID: 36701563; PMCID: PMC9880518.
9. Memirie ST, Tolla MT, Rumpler E, Sato R, Bolongaita S, Tefera YL, Tesfaye L,Tadesse MZ, Getnet F, Mengistu T, Verguet S. Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis. PLoS Med. 2023 Mar10;20(3):e1004198. doi: 10.1371/journal.pmed.1004198. PMID: 36897870; PMCID:PMC10004560.
10. GBD 2019 Meningitis Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023 Aug;22(8):685-711. doi: 10.1016/S1474-4422(23)00195-3. PMID:37479374; PMCID: PMC10356620.
​
11. Tesfaye L, Forzy T, Getnet F, Misganaw A, Woldekidan MA, Wolde AA, WarkayeS, Gelaw SK, Memirie ST, Berheto TM, Worku A, Sato R, Hendrix N, Tadesse MZ,Tefera YL, Hailu M, Verguet S. Estimating immunization coverage at the district level: A case study of measles and diphtheria-pertussis-tetanus-Hib-HepBvaccines in Ethiopia. PLOS Glob Public Health. 2024 Jul 25;4(7):e0003404. doi:10.1371/journal.pgph.0003404. PMID: 39052537; PMCID: PMC11271922.
12. Getnet F, Forzy T, Tesfaye L, Misganaw A, Memirie ST, Geremew S, Berheto TM,Wendrad N, Yihun BY, Mirutse MK, Tsegaye F, Dangisso MH, Verguet S.Inequalities in tuberculosis control in Ethiopia: A district-level distributionalmodelling analysis. Trop Med Int Health. 2024 Dec 5. doi: 10.1111/tmi.14066. Epubahead of print. PMID: 39632696.